CC
NEO icon

Corton Capital’s NeoGenomics NEO Stock Holding History

Corton Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,326
Closed -$209K – 667
2024
Q1 		$209K Buy
13,326
+3,160
+31% +$48.8K 0.08% 405
2023
Q4 		$164K Sell
10,166
-1,313
-11% -$21.5K 0.05% 503
2023
Q3 		$141K Buy
+11,479
New +$171K 0.07% 360

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Corton Capital's NEO Position: Q2 2024 in Review

Corton Capital sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 13,326 shares — an estimated $209K sold.

Corton Capital first reported a position in NEO in Q3 2023 and held it in 3 quarters. The position peaked at $209K in Q1 2024. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Corton Capital reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Corton Capital sold 13,326 NeoGenomics shares in Q2 2024, an estimated $209K.
  • Corton Capital first reported a position in NeoGenomics in Q3 2023 and held it in 3 quarters.
  • Corton Capital's NeoGenomics position peaked at $209K in Q1 2024.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Corton Capital's 13F filing for Q2 2024, filed 14 Aug 2024.